RNAi THERAPEUTICS 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 3

Abstract

RNA interference (RNAi) was discovered less than a decade ago and already there are human clinical trials in progress or planned. A major advantage of RNAi versus other antisense based approaches for therapeutic applications is that here cellular machinery that efficiently allows targeting of complementary transcripts is used, often resulting in highly potent down-regulation of gene expression. Despite the excitement about this remarkable biological process for sequence specific gene regulation, there are a number of hurdles and concerns that must be overcome prior to making RNAi a real therapeutic modality, which include off-target effects, triggering of type I interferon responses, and effective delivery in vivo. This review discusses various types of siRNA, mechanistic aspects of RNAi & the potential areas where RNAi therapeutics are applied. It is anticipated that RNAi will be a major therapeutic modality within the next several years, and clearly warrants intense investigation to fully understand the mechanisms involved. 

Authors and Affiliations

K. Babu Nageswararao, R. Ramakrishna, S. Rao

Keywords

Related Articles

ROLE OF PHARMACIST TOWARDS KNOWLEDGE ATTITUDE AND PRACTICE IN COMPLIANCE WITH HYPERTENSION IN NORTH KARANATAKA IN SOUTH INDIAN CITY A BRIEF OVERVIEW 

It is well known that the management of hypertension reduces the incidence further complications like myocardial infarction, stroke and vascular complications. Hypertension is a major health problem with individual, soci...

PLURIPOTENT STEM CELLS FOR VASCULAR DISEASE THERAPY 

Vascular regeneration for ischemic disease represents an unmet clinical need. The ability to derive and expand homogenous populations of human vascular endothelial cells from either human embryonic stem (hES) cells or hu...

SCREENING AND MOLECULAR CHARACTERIZATION OF BACILLUS SP PR01 FOR THE PRODUCTION OF PROTEASE ENZYME  

The current study was attempted to isolate and characterize the protease producing Bacillus sp. Among the 3 strains isolated from soil sample collected from kuppam region, Chennai, India. One strain (PR01) exhibited pote...

FORMULATION AND EVALUATION OF DENTAL FILM FOR PERIODONTITIS 

Controlled release local drug delivery systems offer advantages compared to systemic dosage forms for periodontitis. The objective of this research was to design and evaluate sustained release dental films containing lom...

MONITORING OF OSTEOPOROSIS TREATMENT 

Osteoporosis is far the most common metabolic bone disease and is often called the "silent" disease, because bone loss occurs without symptoms. People often don't know they have the disease until bone breaks, following t...

Download PDF file
  • EP ID EP124721
  • DOI -
  • Views 88
  • Downloads 0

How To Cite

K. Babu Nageswararao, R. Ramakrishna, S. Rao (2011). RNAi THERAPEUTICS . International Research Journal of Pharmacy (IRJP), 2(3), 38-46. https://europub.co.uk/articles/-A-124721